Curran, Claude A. – Trademark Portfolio
Entity Type: 01
Curran, Claude A. has 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include RAISINCELLO and DRUGDEAD.ORG. The portfolio includes 2 registered trademarks. Filings span 7 Nice Classification classes, led by Class 21 (Housewares) and Class 5 (Pharmaceuticals). This trademark owner is based in Bristol, RI.
849 Hope Street
Bristol, RI 02809
Showing of trademarks Trademarks
Trademark Classifications
Curran, Claude A.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Curran, Claude A. have?
Curran, Claude A. has 10 U.S. trademarks filed with the USPTO. Of these, 2 registered, 6 abandoned, 2 cancelled.
What trademark classes does Curran, Claude A. file in?
Curran, Claude A. files trademarks across 7 Nice Classification classes. The most active classes are Class 21 (Housewares), Class 5 (Pharmaceuticals), Class 32 (Light Beverages), Class 25 (Clothing), Class 44 (Medical Services). Class 21 covers household or kitchen utensils and containers; combs and sponges; brushes.
What are Curran, Claude A.'s most well-known trademarks?
Curran, Claude A.'s registered trademark portfolio includes well-known marks such as RAISINCELLO and DRUGDEAD.ORG. These are among 2 currently registered trademarks in the portfolio.
What is Curran, Claude A.'s trademark registration success rate?
Curran, Claude A. has a 20% trademark registration rate, with 2 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.